Consequently, this study aims to explore the role of FSTL1 in the EMT process of pulmonary fibrosis and its regulatory mechanisms on the NF-κB pathway, providing a novel perspective on the development of therapeutic strategies for IPF. Here, NFKB1 is linked to pulmonary fibrosis.